Beijing Scinovo Laboratories Co., Ltd. (referred to as Scinovo Laboratories) was established in November 2016 and is affiliated to Sunnovo Pharm (successfully listed on the STAR Market of the Shanghai Stock Exchange on June 21, 2021, stock code 688621). In Jinweikai Biological Science and Technology Park in Advanced Business Park, Fengtai District, Beijing, an innovative drug PK/PD research platform with an area of more than 2000 square meters and in line with GCP and GLP standards has been built. The company has a registered capital of 20 million yuan. At present, the total investment exceeds 120 million yuan. It can provide comprehensive PK/PD research services and bioanalysis services meeting GLP standards, including pharmacokinetic bioanalysis services, bioanalysis,  biomarker bioanalysis and pharmacodynamics services, central laboratory services, pathology services and pharmacometrics Studies.